Salinomycin enhances doxorubicin sensitivity through reversing the epithelial-mesenchymal transition of cholangiocarcinoma cells by regulating ARK5

Chemotherapy response rates in patients with cholangiocarcinoma remain low, primarily due to the development of drug resistance. Epithelial-mesenchymal transition (EMT) of cancer cells is widely accepted to be important for metastasis and progression, but it has also been linked to the development o...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Z., Cheng, H., Zhu, H., Cao, M., Lu, C., Bao, S., Pan, Y., Li, Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Divulgação Científica 2017
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561806/
https://www.ncbi.nlm.nih.gov/pubmed/28832761
http://dx.doi.org/10.1590/1414-431X20176147

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561806/
https://www.ncbi.nlm.nih.gov/pubmed/28832761
http://dx.doi.org/10.1590/1414-431X20176147

Ejemplares similares